Joep Killestein (J Killestein)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

European journal of neurology

Journal of immunology (Baltimore, Md. : 1950)

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Theo Rispens, Taco W Kuijpers, Joep Killestein, Zoé L E van Kempen, Karien Bloem
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies. Journal of immunology (Baltimore, Md. : 1950) 212 (4) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Pam C G Molenaar, Samantha Noteboom, David R van Nederpelt, Eva A Krijnen, Julia R Jelgerhuis, Ka Hoo Lam, Gerrieke B Druijff-van de Woestijne, Kim A Meijer, Pim van Oirschot, Brigit A de Jong, Iman Brouwer, Bas Jasperse, Vincent De Groot, Bernard M J Uitdehaag, Menno Michiel Schoonheim, Eva M M Strijbis, Joep Killestein
Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis. Journal of neurology (2024)
Eline Me Coerver, S Janssens, A Ahmed, M H J Wessels, Z L E Van Kempen, M M S Jasperse, F Barkhof, Marcus Werner Koch, J Mostert, B M J Uitdehaag, Joep Killestein, Eva M M Strijbis
The association between age and inflammatory disease activity on MRI in relapse-onset multiple sclerosis during long-term follow-up. European journal of neurology (2023)
Theo Rispens, Taco W Kuijpers, Joep Killestein, Zoé L E van Kempen, Karien Bloem
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies. Journal of immunology (Baltimore, Md. : 1950) (2023)
Ka Hoo Lam, James Twose, Birgit I Witte, Giovanni Licitra, Kim A Meijer, Bernard M J Uitdehaag, Vincent De Groot, Joep Killestein
The Use of Smartphone Keystroke Dynamics to Passively Monitor Upper Limb and Cognitive Function in Multiple Sclerosis: Longitudinal Analysis. Journal of medical Internet research 24 (11) (2022)
Joep Killestein, Zoé L E van Kempen
Vaccination responses in B-cell-depleted multiple sclerosis patients: The role of drug pharmacokinetics. European journal of neurology 29 (11) (2022)
Alyssa A Toorop, Zoë Y G J van Lierop, Eva M M Strijbis, Charlotte E Teunissen, Axel Petzold, Mike P Wattjes, Frederik Barkhof, Brigit A de Jong, Zoé Léonie Elise van Kempen, Joep Killestein
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab. Neurology(R) neuroimmunology & neuroinflammation 8 (1) (2020)